StockDocs
Main Newswire Learn
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
BIOT

Instinct Bio Technical Company Holdings Inc.

BIOTW Nasdaq Perfumes, Cosmetics & Other Toilet Preparations EDGAR ↗
$0.02
+0.00 0.00%

Key statistics

from XBRL data in SEC filings
Market cap ⓘ
—
Revenue (TTM) ⓘ
—
Net income (TTM) ⓘ
—
EPS (TTM) ⓘ
—
P/E ratio ⓘ
—
Dividend yield ⓘ
—
Free cash flow ⓘ
—
Cash ⓘ
—
Total assets ⓘ
—
Gross margin ⓘ
—
52-week range ⓘ
$0.02 – $0.02

AI briefing

from the latest 10-K, 10-Q and 8-K events

Instinct Bio Technical Co Holdings Inc. is a Cayman Islands company that, following a July 2026 business combination, became the combined entity of Relativity Acquisition Corp. and Instinct Bio Technical Company Inc., focused on the cosmetics and toilet preparations industry.

What they do

The company operates in the perfumes, cosmetics, and other toilet preparations industry, based in Tokyo, Japan. Its business is centered on holding and managing its consolidated subsidiaries following the business combination. The company does not generate revenue from operations itself; it functions as a holding company.

Recent performance

The company completed a business combination on July 23, 2026, with Instinct Bio Technical Company Inc. valued at $225 million. There are no financial results reported in the provided excerpts. The company is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Strategy

The company's primary strategy is to serve as the public holding entity for Instinct Bio Technical Company Inc. following the business combination. It issued new ordinary shares as consideration and assumed warrants of Relativity. The company plans to leverage its listing on Nasdaq to support its ongoing operations.

Risks

  • Shell company status — The company is a shell company, which may expose it to additional regulatory risks and limited operating history.
  • Dependence on subsidiary — As a holding company, its value depends on the performance of its operating subsidiaries, which are not described in the excerpts.
  • Warrant dilution — Outstanding warrants exercisable at $11.50 per share could dilute existing shareholders if exercised.
  • No revenue drivers — The company has no identifiable revenue-generating activities in the provided filings, indicating a high-risk investment profile.

Outlook

No forward-looking statements are included in the provided excerpts. The company's near-term focus is on integrating the business combination and maintaining its Nasdaq listing. Future performance will depend on the operations of the acquired business.